Ensuring high vaccination and even booster vaccination coverage is critical in preventing
severe Coronavirus Disease 2019 (COVID-19). Among the various COVID-19 vaccines …

The use of coronavirus disease 2019 (COVID-19) vaccines will play the major role in
helping to end the pandemic that has killed millions worldwide. COVID-19 vaccines have …

We have analyzed BNT162b2 vaccine-induced immune responses in naive subjects and
individuals recovered from coronavirus disease 2019 (COVID-19), both soon after (14 days) …

Delayed dosing intervals are a strategy to immunize a greater proportion of the population.
In an observational study, we compared humoral and cellular responses in health care …

To explore the effects of SARS-CoV-2-mRNA vaccines on innate immune responses we
enrolled 58 individuals who received 3 doses of the BNT162b2 vaccine in a longitudinal …

Background Understanding and measuring the individual level of immune protection and its
persistence at both humoral and cellular levels after SARS-CoV-2 vaccination is mandatory …

The advent of COVID-19 vaccines will play a major role in helping to end the pandemic that
has killed millions worldwide. Vaccine candidates have demonstrated robust humoral …

The standard dosing of the Pfizer/BioNTech BNT162b2 mRNA vaccine validated in clinical
trials includes two doses administered three weeks apart. While the decision by some public …

Since COVID-19 risk of reinfection is of great concern, the safety and efficacy of the mRNA-
based vaccines in previously infected populations should be assessed. We studied 78 …

Abstract Background Since July 13, 2021, a third SARS-CoV-2 vaccine BNT162b2 was
approved in Israel to immunocompromised and seniors 60 years of age or older. We aimed …